Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
15m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m agoCPKC increases dividend by 17.5 percent
41m agoWaldencast announces conclusion of SEC investigation
42m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m agoF5 to Host Analyst and Investor Meeting on May 28, 2026
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc.

About

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 19 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
Apr 16 2026
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
Apr 10 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
Mar 17 2026
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Mar 12 2026
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Financials

Revenue
$7.14 M
Market Cap
$165.66 M
EPS
-0.33

Community Chat

Ask AI

6ix6ixAIEvents